Dr. Peter Fitzgerald is an Interventional Cardiologist and a Professor of Medicine at Stanford University, where he is the Director of the Center for Cardiovascular Technology and the Director of the Cardiovascular Core Analysis Laboratory. Dr. Fitzgerald has led and/or participated in over 100 clinical trials and has published over 350 articles and chapters in medical journals and text books.
In addition to his clinical expertise, Dr. Fitzgerald is able to gain granularity on a technology level, having a PhD in Biomedical Engineering. Furthermore, Dr. Fitzgerald brings extensive venture and start up experience to the fund, having been part of the founding team of more than a dozen medical device start ups, and having been one of the principle founders of Latterell Venture Partners, a large healthcare focused venture capital fund located in Silicon Valley. Dr.Fitzgerald serves on several boards, and is an advisor to many medical device start-ups and multinational healthcare companies.
Mr.Berman is a co-founder of Aetherworks, Apnex, BeneChill, and BridgePoint Medical. In addition he is an investor and board member of Data Sciences Int’l, Lutonix, PharmaCentra and UltraShape. In 2001 he co-founded Velocimed which was sold to St. Jude Medical in 2005. From 1995-2000 Mr. Berman was the President of the Cardiology business of Boston Scientific.Mr. Berman received his BS and MBA degrees from Cornell University in 1979 and 1986, respectively.
Mr. Sebba is serving as Vice President of XT Investments. Prior to joining XT Investments, Yoav served as a partner at Yozma Venture Capital (which is part of the XT Investments portfolio), one of Israel’s leading venture capital firms. Prior to joining Yozma, Yoav served as a project manager at Bank Leumi, one of Israel’s leading commercial banks. Yoav is serving as a board member in ZIM Integrated Shipping Services, NanoPass, CorAssist, IntraTech, Angioslide and EndoCross. Yoav served as a board member in Cognitens (acquired by Hexagon), Kailight (acquired by Optium), Impactia (acquired by eWave), Applied Spectral Imaging, Tevet (acquired by NanoMetris), Yadata (acquired by Microsoft) & Next9. Yoav holds a B.Sc. in Industrial Engineering and Management, with distinction, from the Technion Institute of Technology, and an MBA from the Haifa University.
Ariel Moses is a managing partner & CFO with the Agate Medical Investments VC Funds, leading investments and portfolio managements. Mr. Moses is a board member with the following medical device companies: 'MST'(surgery robotics), 'Tulip'(obesity device), and 'AngioSlide' (angioplasty). Ariel served as CEO & board member with 'Iscare Healthcare B.V.' (medical centers in Europe) - led turn around to profitability and exit by M&A. Mr. Moses is Co-Founder at 'Ilumi labs' (Aesthetic dermatology) and 'Incede' (regulation & validation) where he is also a board member. Prior to Agate: Founder & CEO of 'Clal TIS' (FinTech) of Clal Finance investment company, Analyst and VP with leading financials corporations.